Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02939534 · ClinicalTrials.gov registry record
Antigen Presentation and Lymphocyte Response in Parkinson's Disease
A clinical trial, sponsored by Columbia University.
- Completed
- Registry status
- 95
- Enrollment target
NCT02939534 is a clinical trial that has completed, run by Columbia University. The registered enrollment target is 95 participants.
The verdict
NCT02939534 has completed, sponsored by Columbia University.
- COMPLETED
- Registry status
- 95 participants
- Enrollment target
Study Summary
The way the immune system responds to certain PD-related proteins in PD donors compared to the way it responds in persons without or fewer PD related proteins is not well studied and this study aims to analyze the autoimmune response in each group. The study involves a one time visit involving brief questionnaires and a blood draw of 30 mL (approximately 2 tablespoons) to be collected.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 95 participants |
| Start Date | 2015-02 |
| Est. Completion | 2021-02 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02939534
The ClinicalTrials.gov registry entry for NCT02939534 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 95 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Columbia University, which has 958 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02939534 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02939534 about?
NCT02939534 is a clinical study titled "Antigen Presentation and Lymphocyte Response in Parkinson's Disease". The way the immune system responds to certain PD-related proteins in PD donors compared to the way it responds in persons without or fewer PD related proteins is not well studied and this study aims to analyze the autoimmune response in each group. The study involves a one time visit involving brief...
What is the current status of trial NCT02939534?
This trial is currently completed. The enrollment target is 95 participants. The study started on 2015-02. Estimated completion is 2021-02.
Who is sponsoring clinical trial NCT02939534?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.